Aurobindo Pharma’s step down subsidiary to divest its entire stake in a South African JV | Capital Market News
Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in South Africa, has entered into an agreement with Rene Glyne Family trust to sell and dispose of the entire 24.5% shares held by Aurogen. After the disposal of 24.5% shares held by Aurogen, Aurogen will cease to be the joint venture partner of Novagen BBBEE Invest Co (Proprietary).
Powered by Capital Market – Live News
Click here to connect with us on WhatsApp
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Oct 05 2024 | 10:19 AM IST
